bg-img9.jpg
8.jpg
ISBER 2018 Annual Meeting

Fisher BioServices is pleased to announce our participation at the International Society for Biological and Environmental Repositories (ISBER) 2018 Annual Meeting in Dallas, TX on May 20-24. This year's theme will focus on seizing big opportunities in biobanking through data, collaboration and innovation.  ISBER 2018 is the premier global event in the field of biorepository and biospecimen management and we are honored to showcase our services and products in conjunction with our parent company, Thermo Fisher Scientific at booth #209. 

Topic: Biobanking and Biorepository, Content: Blog..........

The Golden Retriever Lifetime Study: 5 Year of Progress in Veterinary Health and Biobanking

Five years ago Fisher Clinical Services, a part of Thermo Fisher Scientific, embarked on a partnership with the Morris Animal Foundation to take veterinary research to a new level.  Since cancer is the leading cause of death in dogs over the age of two and golden retrievers (GRs) are at high risk of cancer development, Fisher Clinical Services is supporting the Foundation’s efforts in working to define the incidence and risk factors for cancer in man’s best friend.

Topic: Biobanking and Biorepository, Content: Blog..........

Validating the Stability and Durability of Labels After Thawing from Cryogenic Temperatures

Working at cryogenic temperatures presents many challenges. One important element involves ensuring labels remain intact and securely adhered to packaging after application as product moves from ambient temperatures to cryogenic temperatures to thawing at the point of use.

Topic: Biobanking and Biorepository, Topic: Cell T..........

Receiving Finished Pharmaceuticals at the Repository

The value of your work lies in the integrity of your materials. Ensuring pharmaceutical agents are handled properly and maintained at the correct temperature throughout all processes is imperative to maximal long term viability and usability. This means not only during the processing and preparation of finished pharmaceuticals for storage—it also means during the transportation process

Content: Poster, Topic: Public Health Research, To..........

Supporting the Precision Medicine Initiative: The All of Us Research Program

In 2015, President Obama announced the Precision Medicine Initiative, a new effort to revolutionize health and disease treatment.1 Two key components of this initiative are:

Topic: Laboratory Processing, Topic: Biobanking an..........

Determining Optimum Maintenance Temperature for Advanced Therapies, Part 2

As discussed in my previous blog, there are many factors that need to be considered when selecting an effective maintenance temperature. Those factors include volume, handling processes, storage, and equipment. In part two of this blog series, I will focus on the impact that some of these variables can have on determining an optimum maintenance temperature for advanced therapies.

Topic: Cell Therapy Solutions, Topic: Biobanking a..........

Risk Mitigation for Material Transport: The Impact of Re-Using Shippers

Ensuring your material is stored under appropriate conditions is only half the battle in preserving its integrity. Equally as critical is the precarious process of transporting your material to its destination, safely and in the same condition it was sent in. Maintaining the chain of custody is of utmost importance, and a large component of this is based on the vessel selected for transportation. In this blog I will share some key items to consider when selecting shippers to transport your high value material.

Topic: Cold-Chain Logistics, Content: Blog, Topic:..........

Thinking Outside of the Freezer: DNA and RNA Storage

While ultra-low temperatures are the current state-of-the-art solution for biospecimen storage, ambient storage is an interesting option and could be superior in certain limited situations. For many types of samples it’s possible that we will always have to use ultra-low temperatures for long-term storage. For other sample types, such as DNA and RNA, there are alternative solutions.  

Topic: Biobanking and Biorepository, Content: Blog..........

Fisher BioServices Top Five Most Popular Blogs of 2017

2017 has been a year filled with new discoveries in the health and medical R&D space. Through our blog, we have shared great stories of our customers' work and discussed a wide-breadth of topics, focusing on advanced therapies, biological material, and public health research.

Content: Blog, Topic: Biobanking and Biorepository..........

InsideAccess: Minimizing Errors and Saving Time in Drug Receipt Processes

The speed-accuracy trade-off is a well-known phenomenon in psychology for processes requiring human input: the faster you go, the more likely it is that errors will be introduced into the system. This presents a major challenge for complex supply chains that demand both efficiency and accuracy. For example, when handling and distributing sensitive clinical materials, it is essential that the workflow proceed as quickly as possible while minimizing errors.

Content: InsideAccess, Topic: Biobanking and Biore..........

World AIDS Day 2017

December 1st is World AIDS Day. Each year, this day is an opportunity to raise awareness of the AIDS pandemic, unite in the fight against HIV, and remember those lost to an AIDS-related illness. The 2017 World AIDS Day theme is “Increasing Impact through Transparency, Accountability, and Partnerships”. This theme reflects a shift in attitude from crisis toward control, and the role of partnerships in reaching our collective goals.

Topic: Biobanking and Biorepository, Content: Blog..........

Transitioning to a New Biobank Model at a Time of Change: An AstraZeneca & Fisher Clinical Services Perspective

The AstraZeneca (AZ) UK Biobank offers long-term storage of, and rapid access to, ~1 million human biological samples (HBS) from AZ Oncology clinical trials, collaborators and commercial sources. A variety of sample types are managed including normal tissue, tumor tissue, blood/plasma/serum, urine and other excreta, FFPE blocks, glass slides and genetic samples (DNA/blood).

Topic: Biobanking and Biorepository, Content: Post..........